Fidelity Investments
ALDR

Fidelity Investments’s Alder Biopharmaceuticals ALDR Stock Holding History

Fidelity Investments’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,782,567
Closed -$21M – 4437
2019
Q2 		$21M Sell
1,782,567
-5,652
-0.3% -$68.4K ﹤0.01% 1607
2019
Q1 		$24.4M Buy
1,788,219
+168,162
+10% +$2.18M ﹤0.01% 1512
2018
Q4 		$16.6M Sell
1,620,057
-474,034
-23% -$6.07M ﹤0.01% 1631
2018
Q3 		$34.9M Sell
2,094,091
-307,474
-13% -$5.56M ﹤0.01% 1448
2018
Q2 		$37.9M Buy
2,401,565
+427,600
+22% +$6.5M ﹤0.01% 1413
2018
Q1 		$25.1M Buy
1,973,965
+220,726
+13% +$3.19M ﹤0.01% 1623
2017
Q4 		$20.1M Sell
1,753,239
-2,552,068
-59% -$28.5M ﹤0.01% 1721
2017
Q3 		$52.7M Sell
4,305,307
-1,324,493
-24% -$13.8M 0.01% 1281
2017
Q2 		$64.5M Sell
5,629,800
-1,847,184
-25% -$34.2M 0.01% 1185
2017
Q1 		$156M Sell
7,476,984
-33,280
-0.4% -$737K 0.02% 802
2016
Q4 		$156M Sell
7,510,264
-17,468
-0.2% -$454K 0.02% 789
2016
Q3 		$247M Buy
7,527,732
+123,598
+2% +$3.76M 0.03% 575
2016
Q2 		$185M Buy
7,404,134
+840,549
+13% +$22.7M 0.03% 697
2016
Q1 		$161M Buy
6,563,585
+119,461
+2% +$2.77M 0.02% 752
2015
Q4 		$213M Buy
6,444,124
+409,278
+7% +$13.8M 0.03% 630
2015
Q3 		$198M Sell
6,034,846
-330,226
-5% -$14M 0.03% 640
2015
Q2 		$337M Buy
6,365,072
+5,597,094
+729% +$204M 0.04% 454
2015
Q1 		$22.2M Buy
767,978
+400,000
+109% +$11M ﹤0.01% 1690
2014
Q4 		$10.7M Sell
367,978
-399,626
-52% -$7.17M ﹤0.01% 1968
2014
Q3 		$9.73M Hold
767,604
– – ﹤0.01% 2026
2014
Q2 		$15.4M Buy
+767,604
New +$10.8M ﹤0.01% 1909

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments's ALDR Position: Q3 2019 in Review

Fidelity Investments sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 1,782,567 shares — an estimated $21M sold.

Fidelity Investments first reported a position in ALDR in Q2 2014 and held it in 21 quarters. The position peaked at $337M in Q2 2015. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.

  • Fidelity Investments reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Fidelity Investments sold 1,782,567 Alder Biopharmaceuticals shares in Q3 2019, an estimated $21M.
  • Fidelity Investments first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 21 quarters.
  • Fidelity Investments's Alder Biopharmaceuticals position peaked at $337M in Q2 2015.
  • 143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.

Based on Fidelity Investments's 13F filing for Q3 2019, filed 13 Nov 2019.